| Dr Ellen Rowe Rhodes, MD | |
|
37464 Lion Drive, Unit 2, Selbyville, DE 19975 | |
| (302) 564-0004 | |
| (302) 564-0005 |
| Full Name | Dr Ellen Rowe Rhodes |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 3 Years |
| Location | 37464 Lion Drive, Selbyville, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598260580 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlantic General Hospital | Berlin, MD | Hospital |
| Beebe Medical Center | Lewes, DE | Hospital |
| Peninsula Regional Medical Center | Salisbury, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlantic General Hospital Corporation | 2365437837 | 88 |
| Atlantic General Hospital Corporation | 2365437837 | 88 |
News Archive
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
Researchers at Weill Cornell Medicine have discovered how drugs can affect various membrane-spanning proteins in addition to their intended target, potentially causing unwanted side effects.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Preserving good cardiovascular health during young adulthood is one of the best ways to reduce risks of premature heart attack or stroke, according to new research published today in the American Heart Association's flagship journal Circulation.
› Verified 8 days ago
| Entity Name | Atlantic General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871582171 PECOS PAC ID: 2365437837 Enrollment ID: O20070406000230 |
News Archive
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
Researchers at Weill Cornell Medicine have discovered how drugs can affect various membrane-spanning proteins in addition to their intended target, potentially causing unwanted side effects.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Preserving good cardiovascular health during young adulthood is one of the best ways to reduce risks of premature heart attack or stroke, according to new research published today in the American Heart Association's flagship journal Circulation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ellen Rowe Rhodes, MD 9733 Healthway Dr, Berlin, MD 21811-1156 Ph: (302) 564-0004 | Dr Ellen Rowe Rhodes, MD 37464 Lion Drive, Unit 2, Selbyville, DE 19975 Ph: (302) 564-0004 |
News Archive
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
Researchers at Weill Cornell Medicine have discovered how drugs can affect various membrane-spanning proteins in addition to their intended target, potentially causing unwanted side effects.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Preserving good cardiovascular health during young adulthood is one of the best ways to reduce risks of premature heart attack or stroke, according to new research published today in the American Heart Association's flagship journal Circulation.
› Verified 8 days ago
Dr. Marc Kattelman, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: Rr 5 Box 79, Selbyville, DE 19975 Phone: 302-436-9600 Fax: 302-436-6260 | |
Dr. Kristine Marie Griffin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 32427 Lighthouse Rd, Selbyville, DE 19975 Phone: 302-436-9600 Fax: 302-436-6260 | |
Dr. Darlene L. Haupt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 36450 Tidal Rd, Selbyville, DE 19975 Phone: 302-291-6045 Fax: 833-449-3867 | |
Mrs. Sally Hamel Dowling, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 N Williams St, Selbyville, DE 19975 Phone: 302-436-8004 Fax: 302-436-9769 |